Antigen | References | |
---|---|---|
Group 1. Best established & studied | ||
β2GPI | Many, e.g. | 29, 48,49 |
Prothrombin | Many, e.g. | 8, 98, 50 |
Protein C, S | Many, e.g. | 93 |
Annexin V | Many, e.g. | 11, 123,124 |
Group 2. Also accepted but less studied | ||
Thrombin | Â | 141 |
Annexin 2 | Â | 130, 140 |
Complement C4, FH |  | 131–133 |
Kininogens | Â | 31, 51,52,143 |
Kallikrein-related | Â | 52,133 |
FVII/FVIIa | Â | 135 |
Antithrombin III | Â | 137,138 |
Group 3. Pure phospholipids | ||
Cardiolipin (CL) | Many, e.g. | 46 |
PE | Many, e.g. | 31 |
PS, PC, etc. | Many, e.g. | 53 |
Oxidized CL | Â | 54,55 |
Oxidized LDL, other PL. |  | 56–58,147,148 |
Group 4. Often or sometimes included | ||
Plasmin | Â | 128 |
Tissue factor (TF) | Â | 134 |
TF path. inhibitor (TFPI) | Â | 130, 309 |
TPA | Â | 60,129 |
Platelet activating factor (PAF) | Â | 153 |
CD40/CD40L | Â | 154 |
Group 5. Associated or candidate aPL | ||
CD36 | Â | 157,158 |
Thrombomodulin | Â | 32 |
EPCR | Â | 61,63 |
Phospholipase A2 | Â | 156 |
Group 6. Implicit under definition | ||
FVIII | Many, e.g. | 63–66,141 |
FX | Â | 16 |
FXI | Â | 52,67,155 |
FXII | Â | 68,161 |